# Edgewise Therapeutics announces Expansion of their EDG-5506 clinical program in Duchenne muscular dystrophy
**FDA Update**

**2023-10-26 12:12**

**https://www.ainvest.com/news/edgewise-therapeutics-announces-expansion-of-their-edg-5506-clinical-program-in-duchenne-muscular-dystrophy-2310100081959155965ffb36/**

Edgewise Therapeutics announces Expansion of their EDG-5506 clinical program in Duchenne muscular dystrophy